Larissa Hammer
About Larissa Hammer
Larissa Hammer is a Regulatory Affairs Specialist at Bristol-Myers Squibb in New Jersey, with over a decade of experience in regulatory affairs and a strong background in chemistry and drug development.
Current Role at Bristol-Myers Squibb
Larissa Hammer is a Regulatory Affairs Specialist at Bristol-Myers Squibb, based in New Jersey, United States. She has been with the company since June 2011, focusing on developing and implementing regulatory strategies and ensuring compliance with regulatory requirements. Her role involves collaborating with various departments to streamline the drug approval process and maintain compliance with industry standards.
Previous Roles in Regulatory Affairs and R&D
Prior to her current role, Larissa Hammer gained experience working at CSL in King of Prussia, Pennsylvania. She worked as a Regulatory Affairs Officer from 2009 to 2011, for two years, where she contributed to regulatory submissions and compliance efforts. Before transitioning into regulatory affairs, she served as an R&D Scientist at CSL from 2005 to 2009, where she was involved in research and development projects.
Educational Background in Drug Development and Chemistry
Larissa Hammer holds a Master's degree in Drug Development from UNSW, which she earned between 2007 and 2009. She also has a Bachelor of Science degree in Chemistry from Monash University, completed from 1998 to 2002. Her educational background provides a strong foundation in both scientific and regulatory aspects of the pharmaceutical industry.
Experience in the Pharmaceutical Industry
With over a decade of experience in regulatory affairs at Bristol-Myers Squibb, Larissa Hammer has a comprehensive understanding of the regulatory landscape. She has a proven track record of transitioning from an R&D Scientist role to a Regulatory Affairs Officer and, ultimately, a Regulatory Affairs Specialist. Her combined expertise in chemistry and drug development enables her to effectively navigate and manage the complexities of regulatory compliance.